KEY NOTE SPEAKERS

  • Axel Boehnke

    Director Market Access Europe North

    PTC Therapeutics

  • Johan Holmström

    Global Pricing and Market Intelligence, Dental Implants

    Dentsply Sirona

  • Jörg Mahlich

    Head of Health Economics and Outcomes Research

    Janssen pharmaceutical

  • Ryotaro Ishikawa

    Global Market Access Director

    Novartis

  • Sebastian Gensior

    Managing Director

    Global Health Access Solutions

  • Ruven Remo Eul

    Senior Principal, Global Pricing and Tender Management

    HighPoint Solutions

  • Fabrizio Gianfrate

    Professor of Health Economics

    University of Ferrara, Luiss Business School Rome, Italy

  • George Boretos

    CMO

    Cube RM

  • Sandra Garitonandía

    Business Development Manager for Life Sciences

    Vistex EMEA

  • Magdi Stino, MBA,MS,PhD

    Product Manager

    EVERSANA

  • Muge Gurevin

    TWAL Tender & Pricing Manager

    MEDTRONIC

  • Stefan Krojer

    Head of Strategic Procurement

    Johanniter Competence Center GmbH

  • Josh Bedel

    Sr. Director Pricing and Market Access

    Clovis Oncology

  • Miroslav Tlustý

    Head of pricing

    Dr.Max pharmacies

  • Daniel Brath

    Senior Pricing Manager, Global Patient Access

    Novo Nordisk A/S

  • Pavel Slanina

    Head of Pricing and Market Intelligence

    ZENTIVA

  • Jonathan Hodgson

    Senior Principal

    Promidian and EVERSANA Company

  • Judith Imhof

    Head of Pricing & Bids

    Olympus Medical Systems Division (EMEA HQ)

  • Markus Pöttker

    Post Market Surveillance MDR Lead

    Smith+Nephew

  • Richard Rahul

    Senior Manager

    Monitor Deloitte Belgium

  • Sarah Pitluck

    Head,Global Pricing and Reimbursement

    SPARK THERAPEUTICS

  • Sara Carvalho

    Title Senior Consultant, Global Pricing and Contracting

    HighPoint Solutions, an IQVIA Company

  • Cornelia Roibu

    Consultant

    Parexel Access Consulting

  • Michael Tang

    Senior Principal, P&MA

    Parexel

  • Giuseppe Monita

    Director, Contracts, Tendering & Customer Services EMEA

    Biocompatibles UK ltd, a Boston Scientific Company

  • Filippo Gabbia

    EMEA Strategic Tender Lead Medical Devices & Vice Chair of MedTech Public Procurement WG

    Johnson & Johnson

  • Maarten Moreels

    Director

    Monitor Deloitte Belgium

  • Hans Demeyere

    Senior Manager

    Monitor Deloitte Belgium

  • Luca Porro

    Sr. Manager Pricing, Global Cardiovascular and Europe Neuromodulation

    LIVANOVA

 

Pricing in a complex ecosystem  

dealing with transparency, collaborative relationships and smart data

 

The 9th annual EPP Life Sciences Pricing Forum will provide you with the latest knowledge on pricing trends, industry best-practices and will equip you with the tools necessary to empower your success. The theme of the forum will orbit around: Pricing in a complex ecosystem – dealing with transparency, collaborative relationships and smart data.

Our forum will enable you to make connections with over 100 industry leaders, share pioneering content and discuss the latest practices impacting pricing in the complex Life Sciences’ ecosystem. We will discuss new pricing strategy, effective collaboration with payers and other stakeholders, usage of data and technology to optimise pricing strategy, market access models, price policy and innovative pricing tools.

You will get access to exclusive content, 15+ expert presentations, 10+ case studies, 4+ workshops, 2+ Roundtable discussions, 2+ panel sessions and an incredible and entertaining evening event tailored to facilitate networking between Life Sciences industry leaders!

 

If you would like to share your knowledge on this upcoming forum, please contact our Conference Producer: camila.rios@pricingplatform.eu

or our Learning Development & Partner Relationships Manager: britt.dejager@pricingplatform.eu

You can also reach us at: +32(0)473.71.76.69

Pre-order the brochure now and have it sent to you as soon as it is ready. Just fill in your details when clicking the download brochure button.

 

 

 

Are you an influencer or specialized in pricing based on AI, machine learning – or agile pricing strategies in a digital world? we want to hear from you !

If you would like to contribute to this unique forum,
please contact Camila Rios at Camila.rios@pricingplatform.eu

         

The 8th EPP Life Sciences Pricing Forum was a big success in 2018!
Relive it now.


If you would like to be part of this amazing forum next year : please contact us:
camila.rios@pricingplatform.eu or  britt.dejager@pricingplatform.eu or just give us call +32(0)473.71.76.69 


5 reasons why you should attend the EPP Life Sciences Pricing Forum in 2019 

  1. You will acquire the latest knowledge on pricing trends, industry best-practices and the tools necessary to empower your success.
  2. 100+ senior industry leaders come together for exclusive keynote presentations, innovative workshops, breakouts on Pharma and MedTech, roundtable discussions and unrivaled networking to engage in high level discussions that will shape the future of pricing and market access in Life Sciences
  3. The forum agenda is created together with key industry influencers to include the most relevant and up-to-date content
  4. 18+ Speakers delivering interactive workshops, roundtables, panel discussions and ground-breaking presentation
  5. Pharma & MedTech Breakouts: Discuss, learn and challenge both strategic and tactical topic

Who will be attending?

Every year 100+ medtech and pharma industry delegates gather to discuss and reflect on the latest pricing and market access trends. The goal is to provide you with knowledge about best business practices and offer you a chance to meet world’s best experts in pricing and profit optimisation.

The EPP Life Sciences Pricing Forum brings together leading practitioners and experts to discuss, reflect, network and share. The forum is tailored for key stakeholders such as: Pricing, Reimbursement, Market Access, Commercial, Marketing and Sales Directors and VPs, CEOs and General Managers.

Please do not hesitate to contact us if you would like to get more information: camila.rios@pricingplatform.eu 

 


 

This is an event you must attend!

  • 1 BUILD RELATIONSHIPS

    With more than 1000 minutes of network opportunity, you have plenty of time to connect with pricing colleagues from all over Europe.

  • 2 DISCUSS

    We stimulate an atmosphere of discussion and interaction, the best way to learn.

  • 3 LEARN FROM THE BEST

    A carefully selected speaking team of top pricing professionals, all active within your industry. No general talk, but only to-the point and useful presentations.

  • 4 REFLECT & PRACTICE

    Reflect on your key priorities and how to make it really happen !  Translate your key learnings into real change.

THE PROGRAMME

We are working on the upcoming program 2019.

If you want to keep updated, please request the brochure (see top right in navigation).  As soon as the new brochure is available, we will send you the program !

14 Oct
13.00-15.30
WS 1: Simulation Game – Tender Management: From Planning to Winning Ruven Remo Eul & Sara Carvalho - HIGHPOINT, AN IQVIA COMPANY



14 Oct
13.00-15.30
WS 2: How Cell and Gene Therapies are Redefining the Traditional Pharmaceutical Pricing & Reimbursement Model Michael Tang & Cornelia Roibu - PAREXEL



14 Oct
16.00-18.30
WS 3: Beyond Price Management: A 3-step Guide to Boost your Margin PHARMA + MEDICAL DEVICES Sandra Garitonandía - Vistex EMEA



14 Oct
16.00-18.30
WS 4: Pricing and Valuing Digital Therapies: PHARMA + MEDICAL DEVICES Eversana Magdi Stino & Jonathan Hodgson - EVERSANA



October 15th 2019
Session 1: Collaborative pricing and market access in the increasingly transparent Life Sciences industry ecosystem ------------------------------------------- - -------------------------------------------
8.40 Welcome by EPP President Pol Vanaerde - President - European Pricing Platform (EPP)
Audience Polling - through EPP Mobile App

Ice breaking polling session to understand the reasoning behind the delegates attendance to the event. (sub-groups will be created for lunch)

8.50 Chairman’s Opening Remarks Contracts, Tendering & Customer Services EMEA - BOSTON SCIENTIFIC
9.00 Innovative Hospital Procurement meets Supplier Collaboration Stefan Krojer, Head of Strategic Procurement - JOHANNITER COMPETENCE CENTER GmbH

• Listen about the future of hospital procurement and its implications
• Understand how hospitals and suppliers can collaborate in this scenario
• Explore this with real cases and success stories

9.30 Evolution of the drug price in a global increasing challenging reimbursement scenario Prof. Fabrizio Gianfrate, Full-time Professor of Health Economics - UNIVERSITY OF FERRARA

• Understand the pressing drivers impacting the reimbursement landscape
• Get a view of the potential companies’ strategies to react to the changes
• New pricing and reimbursement model and win win potential solutions

10.00 What happens to prices after they are set by the industry Miroslav Tlustý - Head of pricing - Dr.Max pharmacies
  • Listen from one of the biggest retailers in Central Europe and understand what happens to prices after they are set by the industry
  • Explore how products are priced differently in the countries where Dr.Max is active (PL,SK,RO,IT,SRB)
  • Understand the approach of Dr.Max and the role of their pricing strategy in becoming one of the country’s leading healthcare retailers in Central Europe
10.30 Interactive Panel Session: Consolidation and acquisitions, the impact of mergers on pricing
  • Understand how consolidation and acquisition of private and public institutions is impacting the industry and increasing transparency and communication between parties
  • Hear about the consequences of these
  • Explore best practices to drive collaboration between parties involved

 

Filippo Gabbia, Moderator

Fabrizio Gianfrate – Panellist

Miroslav Tlusty – Panellist

11.00 Coffee Break and Networking
11.30 Breakout Session
PHARMA MEDTECH
Decrypting the differential pricing concept and pricing regulations in the US and its impact in EU

  • The proposed Part B IPI regulation and its impact for EU
  • Understand the differential pricing effects in US vs. EU vs. ROW and what can we learn from these findings of differential pricing
  • Explore different strategies to follow to approach different market scenarios to ‘protect pricing’ in EU and US and what implications will the industry face as a result.

Richard Rahul, Senior Manager, MONITOR DELOITTE BELGIUM

Maarten Moreels, Director, MONITOR DELOITTE BELGIUM

Medical Device Regulation – what will happen when the transition time is over?

  • Explore the current medical device regulation landscape
  • Understand the EU and US QMS requirements
  • Learn about different strategies to approach the market alterations to optimise pricing strategy

Markus Pöttker, Post Market Surveillance MDR Lead, SMITH + NEPHEW

12.00 Lunch & Networking

Audience Polling Lunch – Join the group with the same topic of interest to discuss over lunch and enjoy casually chatting with other industry players over a delicious lunch.

Session 2 · Innovative Pricing Models in Life Sciences ------------------------------------------- - -------------------------------------------
13.00 Contracting Innovation: What other industries are doing and what can we learn from them Ryotaro Ishikawa, MD MBA, Global Market Access Director - NOVARTIS

• Learn how to communicate cost effectiveness, efficiency and added value of different therapies
• Hear about other industries as inspiration on how to be tested within our industry
• Explore two models: The Subscription Economy and The Power of the Hour Model

14.20 Applying innovative insurance solutions to help future proof healthcare systems Sebastian Gensior, Managing Director - GLOBAL HEALTH ACCESS SOLUTIONS
  • Understanding the current public health systems challenges to fund future high-price medicines
  • Explore innovative insurance solutions to allow higher penetration of this strategy and tackle the issue
  • Discuss how learning from the financial sector can disrupt healthcare insurance via a sandbox approach
14.00 The Economics of Value Jörg Mahlich, Head Health Economics and Outcomes Research - Jannsen Pharmaceutical Companies of Johnson and Johnson
  • This presentation outlays the concept of value from an economics perspective
  • Learn how concepts such as willingness to pay, value based pricing, or welfare can be applied to the healthcare market
14.30 The Transaction Price Opportunity: A Guide to Maximize its Value Sandra (Alejandra) Garitonandía Puig, EMEA LifeSciences Manager - VISTEX
  • List Price vs Net Price: When you analyse your Gross-to-Net, do you know which pricing elements matter?
  • Learn how to define and gain control of the transaction price in the most effective way
  • Explore possibilities that a strategic view of Gross-to-Net can bring you
15.00 Coffee Break and Networking
15.30 Break-out
PHARMA MEDTECH
Case Study: A pragmatic approach to outcome-based pricing in Gene Therapies

  • HTA initiatives to value expensive drugs[i.e. cost effectiveness, relative effectiveness]
  • Innovative reimbursement models for specialty products[i.e. pay for performance, risk sharing, value-based pricing, coverage with evidence development]
  • Case studies of implementation in Gene and Cell Therapies so far

Axel Boehnkle, Director Market Access, EU North, PTC THERAPEUTICS

Case Study: Stop selling products, start selling solutions – create a differential value proposition through innovative bundles

  • Leverage new business opportunities from existing product portfolio – a customer-oriented approach
  • Maximize business uptake with a customer driven value proposition and pricing strategy
  • Solution selling – a shift in mindset for you, your sales team and the customer – challenges and opportunities

 

Johan Holmströrm, Manager Global Pricing and Market Intelligence, DENTSPLY SIRONA IMPLANTS

How to identify and reduce your GtN leakages?

  • How to bring full visibility on the Gross to Net and identify value leakages
  • How to structure the commercial policy to steer customer buying behavior towards profitable growth
  • What are concrete examples of ‘sales boosters’ and how to configure these

 

Maarten Moreels, Director, MONITOR DELOITTE BELGIUM

Hans Demeyere, Senior Manager, MONITOR DELOITTE BELGIUM

Case Study: Tendering & pricing innovation in action 

  • Learn how to take the lead in business model innovation
  • Understand how to succesfully adopt key strategies to deliver great results year after year
  • Hear about a real case study to showcase these strategies

 

Muge Gurevin, Senior Tender, Deal Desk & Pricing Manager, MEDTRONIC

Interactive Campfire Storytelling Session

 Be ready to share your own pricing experiences with others!

Be ready to discuss the topics covered in the conference so far, and how you plan to use the knowledge gained into your role.

 Interactive Campfire Storytelling Session Be ready to share your own pricing experiences with others!

Be ready to discuss the topics covered in the conference so far, and how you plan to use the knowledge gained into your role.

 

17.00 ROI Calculator for tenders George Boretos, CMO - CUBE RM
  • See what the usual challenges in tendering are and their importance in tender performance
  • Quickly identify areas where the company is performing well or if it needs further improvement
  • Estimate the impact in revenue and profitability against the investment needed and, therefore the Return on Investment
  • Building a business case for investment in tender capabilities and tool
17.15 Using the Value Based Procurement framework to capture the value of your products in Tender Filippo Gabbia, EMEA Strategic Tender Lead Medical Devices & Vice Chair of MedTech Public Procurement - JOHNSON & JOHNSON

• Understand the Value Based Procurement framework
• Lesson learnt from the implementation of a Value Based Approach to multiple products
• Examples from published tenders

17.00 Closing Remarks of the Chairman
October 16th 2019
Technology, SmartData and AI changing the pricing and tendering function in Life Sciences ------------------------------------------- - -------------------------------------------
8.50 Chairman’s Opening Remarks Axel Boehnke, Director Market Access, EU North - PTC THERAPEUTICS
9.00 Automatic Tender Discovery using Natural Language Processing and Machine Learning George Boretos, Chief Marketing Officer - CUBE RM
  • Learn how you can use advanced technologies, like Natural Language Processing to automatically discover thousands of Public Tenders across Europe that are relevant to your business.
  • Automatically qualify tenders (Bid/No Bid guidance) leveraging historical information, information coming from online tender sources, and machine learning.
  • Plan ahead for tenders not yet published using machine learning, tender seasonality, and product life cycle.
9.30 Analyzing and Predicting the trade-offs between reimbursement, price, and time-to-market Dr. Magdi Stino, MBA, MS, Phd, Product Manager - EVERSANA

• Conceptual framework for looking at factors that influence reimbursement decisions for HTAs in EMA markets
• Review different approaches to modeling and predicting such topics as time-to-market, price, and access tradeoffs post-EMA authorization
• Discuss how HTA decisions may impact subsequent price trends

10.00 Addressing the Global and Local needs of Effective Tendering Ruven Remo - Director, Life Sciences - Highpoint Solutions
  • Explore insights through Practical Experience and Benchmarks from the Industry
  • Understand how the Life Sciences Procurement has been evolving across the globe and how to effectively address its needs within tendering
  • Hear about the 2nd Tender Benchmarking Study
10.30 Coffee Break and Networking
11.00
PHARMA MEDTECH
Case Study: Early learnings and reflections on Value-based contracting in chronic care

  • Value-based contracting – “start with why”
  • Value-based contracting in chronic care – “the least likely case”
  • Learnings from around the world – “it’s all about data and mindset”
  • Reflections on the future of value-based contracting

Daniel Brath, Senior Global Pricing Manager- NOVO NORDISK

Case Study: European E-Public Procurement: Business Opportunities and Barriers for SMEs.

  • Learn how to increase efficiency centralizing the main tender processes
  • Discover the roadblocks that are hidden behind the technology (e-procurement)
  • Shape the future of Tender Management Company Organizations
  • A case study of successful tendering model to maximize efficiency

 

Giuseppe Monita, Director, Contracts, Tendering & Customer Services EMEA, BOSTON SCIENTIFIC

 

Case Study: Expectations vs. Reality for pricing the multi-indication oncology drugs

  • Challenges and opportunities when setting correct pricing strategy for multi-indication oncology drugs within an uncertain and fast-evolving competitive landscape.
  • Are innovative pricing schemes and data analytics sufficient to stay compliant to the pricing strategy at the execution stage?
  • Case studies from innovative oncology drugs

 

 

Josh Bedel, Sr.Director, Pricing and Market Access. CLOVIS ONCOLOGY

Understanding and optimizing pricing of acquired businesses: challenges and opportunities

  • Learn how the Pricing Team can have an impact on the success of M&A activities
  • Understand how to assess the target’s pricing strategy and contribute to the financial valuation
  • Challenges and opportunities in optimizing the pricing strategy of acquired businesses
  • Case studies from recent acquisitions

 

Luca Porro, Sr. Manager Pricing, Global Cardiovascular and Europe Neuromodulation, LIVANOVA

Roundtables Discussions

  • Applying technology to reduce time of pricing cycle process
  • Sharing of best practices of succesful technology application to the pricing process
  • Using SmartData to demonstrate the value of your product effectively and capture it through price
Roundtables Discussion

  • Applying technology to reduce time of tendering cycle process
  • Sharing of best practices of successful technology application to the pricing process
  • Using SmartData to demonstrate the value of your product effectively and capture it through price.

 

12.30 Lunch & Networking (1 hour)
Session 4: Staying relevant in the complex pricing ecosystem ------------------------------------------- - -------------------------------------------
13.30 Judith Imhof, Head of Pricing & Bids - OLYMPUS EUROPA
  • Which pricing topics to tackle first when implementing price management in an organization?
  • Why is value-based pricing argumentation a key for sustainable price management implementation?
  • Which organizational elements are necessary to enable the organization driving the change?
14.00 Driving and enhancing the value and visibility of the pricing function through successful and effective collaboration with the sales and marketing teams Pavel Slanina, Head of Pricing and Market Intelligence - ZENTIVA
  • Why we need to evolve our communication and way of working to keep the attention of the marketing and sales teams
  • Practical take-away tips and tricks based on real-life examples from my practice working on price increase projects across Europe.
  • Case study highlighting what can be achieved
14.30 Inspirational Closing: Overcoming Industry Challenges - Pricing & Reimbursement for Gene Therapies Sarah Pitluck, Head, Global Pricing & Reimbursement - SPARK THERAPEUTICS

• Negotiating price and securing reimbursement for advanced therapy medicinal products (ATMPs) raises a set of new challenges, different from access challenges for more traditional chronic therapies.
• LUXTURNA was the first one-time gene therapy to be approved by both the FDA and EMA for the treatment of patients with inherited retinal dystrophy caused by RPE65 gene mutations.
• Spark offered a unique menu of pricing and reimbursement options to secure patient access in the US.
• Hear about Spark’s experience in the US and how they overcame these challenges.

15.30 Closing remarks of the Chairman & President Axel Boehnke, Director Market Access, EU North - PTC THERAPEUTICS
18.45 Evening Activity – Highpoint Solutions Benchmark Study Results Presentation

Contact Forum Producer

Camila Rios

PRE FORUM WORKSHOPS

Interested in delivering a Workshop ?

This can be your space to tell the industry about your innovative solutions and products.
Contact Camila Rios, e: Camila.rios@pricingplatform.eu

WS 1: Simulation Game – Tender Management: From Planning to Winning

14Oct13.00-15.30

This workshop is intended for those responsible for pricing, contracting and tender management who would like to master the core principles for successful contracting and tender management within Life Sciences.

  • Practical techniques and tools to be used in tendering processes
  • Participate on a simulation game on tender management to work out tender pricing and competition strategies supporting a healthy P&L management

Ruven Remo Eul & Sara Carvalho () HIGHPOINT, AN IQVIA COMPANY

WS 2: How Cell and Gene Therapies are Redefining the Traditional Pharmaceutical Pricing & Reimbursement Model

14Oct13.00-15.30

This workshop will aim to explore in more detail some of the challenges posed by C&GTs, specifically from a P&R perspective. Key areas of focus and discussion will include the following:

  • Tools to bridge the gap from regulatory approval to reimbursement for C&GTs (making RCTs more payer-relevant, leveraging RWE, innovative P&R) – why has the focus been on innovative P&R?
  • Examples of innovative P&R models that could be relevant for C&GTs including how recently approved C&GTs have fared. What are the pros and cons of these innovative schemes? How can real-world data help?
  • How the advent of C&GTs is likely to pose additional challenges for the broader “health ecosystem”(e.g. including classification, coding and manufacturing)? What original challenges do these pose for manufacturers and payers and how can these be resolved?”

Michael Tang & Cornelia Roibu () PAREXEL

WS 3: Beyond Price Management: A 3-step Guide to Boost your Margin PHARMA + MEDICAL DEVICES

14Oct16.00-18.30

During this workshop, we will analyse how to boost the sales margin by making corrections on the revenue leakages side and how to increase sales profit or generate new sources of revenue.

  • Understand the different levels of Revenue Management Strategy beyond “Price” in an interactive workshop with various examples and exercises which will provide you with an innovative perspective and take-aways that can be quickly applied to optimise this process.
  • Learn about Margin Management- or the ability to understand where money is made and lost in your business and how to get the company’s full control and visibility to boost your margin.

Sandra Garitonandía () Vistex EMEA

WS 4: Pricing and Valuing Digital Therapies: PHARMA + MEDICAL DEVICES

14Oct16.00-18.30

Digital therapies are an exciting new area for innovation, as digital diagnostics and digital therapies provide significant new areas of value in healthcare. Companies like Foundation Medicine, Cognoa, Pear Therapeutics, and others are created outcomes-oriented software-driven digital diagnostics and therapies for patients, hospitals and payers that change health outcomes. Meanwhile, many digital devices have their own ecosystem of health information, like continuous glucose monitoring, that can impact health, and further non-traditional healthcare companies like Apple, Google and others enter into this space with consumer devices like the Apple Watch with its ECG capabilities.

 

  • Understand how these therapies get valued, priced and reimbursed
  • Explore what monetization models should all health manufacturers be aware of as they look to extend their own products with a broader software ecosystems strategy
  • Learn how to evaluate this important and growing space

Eversana

Magdi Stino & Jonathan Hodgson () EVERSANA

KEY NOTE SPEAKERS

If you would like to join the speaker faculty, please contact Camila Rios : Camila.rios@pricingplatform.eu

Axel Boehnke

Director Market Access Europe North

PTC Therapeutics

Axel Boehnke is a Health Economist, with a master’s degree on Health and Medical Management, currentlyresponsible for EU North as Director Market Access at PTC Therapeutics. Working in pharmaceutical industry for over 15 years allowed him to develop a strong market access skill set with proven track record, executed in Oncology, Autoimmune Diseases, (Ultra) Orphan Diseases, Hepatology, anti-virals, from Humira-franchise business at Abbott, in Servier and deep diverse Biotech Experience. He is a member of the Germany Society of Market Access and the German Society of Health Economics. Before joining the industry, he worked on a German payer organisation.

Johan Holmström

Global Pricing and Market Intelligence, Dental Implants

Dentsply Sirona

Johan Holmström has long and broad experience from leading innovations in various roles in product development, marketing and pricing management. He is currently heading up a team responsible for global strategic pricing of a portfolio with hardware products, software solutions and services. In this role he is leading market intelligence and pricing strategies but also activities to turn them into sustainable business through innovative go-to market and commercialization models.

Johan holds a MSc in engineering from the Royal Institute of Technology, Stockholm and has continued his lifelong learning with additional studies in marketing and business administration.

Jörg Mahlich

Head of Health Economics and Outcomes Research

Janssen pharmaceutical

Jörg Mahlich is head of Health Economics and Outcomes Research at Janssen pharmaceutical companies of Johnson and Johnson in Germany. In addition, he is lecturer of Health Economics at the Economics Department of the University of Vienna and research affiliate at the Düsseldorf Institute for Competition Economics (DICE) of the University of Düsseldorf, Germany. Previous to that he hold different positions in industry and consulting in Austria, Germany, and Japan. He is interested in global pharmaceutical economics and policy. Jörg graduated in economics from the University of Kiel, Germany and holds a doctoral degree in economics from the University of Vienna, Austria.

Ryotaro Ishikawa

Global Market Access Director

Novartis

Ryotaro Ishikawa, MD MBA, with more than 20 years of experience in healthcare industry, is dedicated to test and trial innovative solutions for customers, patients and stakeholder in different geographies. International executive passionate about building high performance teams in Marketing and Sales, Market Access, HEOR in emerging markets.

Experienced in driving value/evidence generation strategy within a cross-functional matrix for HTA Markets including Europe, Latin-America and Asia.

 

Sebastian Gensior

Managing Director

Global Health Access Solutions

Sebastian is the managing director of Global Health Access Solutions, where he provides clients with market insights and go-to-market strategies. Over the past seven years, he held multiple market access and health policy positions in the pharmaceutical industry, most notably at Roche and Edelman. He has supported pharmaceutical and medical devices clients in understanding healthcare markets around the world and was actively involved in healthcare reforms. Sebastian is constantly exploring innovative pricing and insurance solutions and bringing them to the market.

 

He holds a Bachelor in European Public Health from the University of Maastricht.

 

Ruven Remo Eul

Senior Principal, Global Pricing and Tender Management

HighPoint Solutions

Ruven is a Director within the European Life Sciences team based out of Zug, Switzerland responsible for project oversight and delivery, resource management and solution development in the areas of Pricing, Contracting and Tendering. Ruven brings a background of industry experiences in large pharma from companies such as Pfizer and BMS where he worked in Commercial roles with a large focus on leading cross functional Tendering teams for Pfizer in Germany. While at HighPoint Solutions, Ruven has worked with emerging, mid-tier and large pharma on various Tendering and Contracting programs from policy and process assessments, outsourcing of business functions, software vendor evaluations and implementation of global programs. Additionally, Ruven has conducted the industry’s first Benchmarking Study on Tendering issuing 4 reports presenting the benchmarking results and developed HighPoint’s Tender Data Service THOR focusing on supporting the awareness & planning phase of Tendering while building Competitive and Pricing Intelligence. In parallel, Ruven has also worked deeply in global commercial effectiveness programs.

Fabrizio Gianfrate

Professor of Health Economics

University of Ferrara, Luiss Business School Rome, Italy

Phd and Masters in Health Economics (Rome, Stockholm, York). Master in Economic Journalism.

Full Professor of Health Economics, Market Access Consultant, Columnist. Ex-payer as AIFA member (pricing and reimbursement committee), Regional HTA Committees member (several Regions), Director at Ministry of Health (appointed), General Manager and Vice President of GSK Foundation Italy and of Angelini Foundation, several director roles in pharmaceutical industries, secondments in UK and US.

Past: Director of several magazines on healthcare and pharma, formers member of Farmindustria, Assobiotech, CENSIS, EFPIA, Federfarma.
Actual: Board Member of Italian Society of Pharmacoeconomics and Ethicals and Italian society of Healthcare studies).
Author of more than 700 articles and 7 books.

George Boretos

CMO

Cube RM

George is the CMO of Cube RM, a vendor of Revenue Management & Optimization solutions with specialization in Tender Management & CPQ software. He has more than twenty years of professional experience in managerial positions in pricing, product marketing, corporate strategy, and sales. He is also a seasoned data scientist, specializing in price optimization models, with numerous successful business forecasts and scientific publications to his name in prestigious scientific journals and publishers, such as Elsevier and Foresight. He is a member of the International Institute of Forecasters.

Sandra Garitonandía

Business Development Manager for Life Sciences

Vistex EMEA

Alejandra (Sandra) Garitonandía is the Business Development Manager for Life Sciences at Vistex EMEA. She is a Life Sciences passionate and specialized in Revenue & Margin Management for Pharma. She has a background in medical and business educational studies but also a broad experience as an IT professional. During her international career she hold different positions in business and IT in Pharma. Her specialization area is where business processes meet the IT systems and how to support efficient End-to-End Revenue Management.

Magdi Stino, MBA,MS,PhD

Product Manager

EVERSANA

Dr. Magdi Stino is a Product Manager for Eversana, Inc. and leads their efforts in aggregating data from and analyzing HTA decisions across the globe.  He earned his PhD in Health Policy from the University of the Sciences in Philadelphia as well as an MS in Health Economics and an MBA.  His post-doctoral work was for the Massachusetts Institute of Technology (MIT) Financing and Reimbursement of Cures in the US (FOCUS) project which explored financing solutions for ultra-expensive curative therapies emerging from the pipeline.  Prior to joining Eversana, he worked as a market access and health economics consultant.

Muge Gurevin

TWAL Tender & Pricing Manager

MEDTRONIC

Senior commercial process leader with 15 years of broad and multinational experience in Healthcare, IT & Telecommunications, Audit companies. Strong technical and operational background in sales, commercial & digital operations, technical product management, CRM management, project & tender management, pricing, financial analysis, business operations & intelligence, funnel and Sales Force Effectiveness and team management.

Stefan Krojer

Head of Strategic Procurement

Johanniter Competence Center GmbH

Stefan Krojer is a passionate purchaser and Head of Strategic Procurement at Johanniter Competence Center GmbH, Berlin. His career began at the hospital group Rhön-Klinikum. He gained his sales experience while working for the Group Purchasing Organization P.E.G. As a result, he was responsible for the project management for the logistics company Hospital Logiserve. As Head of Supply Chain Management at the St. Marien-Hospital Berlin he gained practical experience in the hospital procurement. With his study “Hospital Procurement 2025” published in June 2017, he is using his “Future Hospital Procurement” blog to promote transparency and dialogue between partners in hospital procurement. His specialty is digitization in hospital purchasing. He is a pioneer in social buying and social collaboration.

Josh Bedel

Sr. Director Pricing and Market Access

Clovis Oncology

Josh Bedel is Senior Director for Pricing and Market Access – Europe based in Zurich, Switzerland. He brings broad experience and holistic approach to pricing and market access through various roles held across ranging functions in pharma and biotech industry such as health economics, pricing and market access, commercial effectiveness, and business IT. He is specialized in setting and executing multi-dimensional pricing strategies to drive fast market access in Europe as well as emerging markets around the world. Josh holds Bachelor’s degree in management and Economics and Master’s degree in Finance with focus on M&A in pharmaceutical industry.

Miroslav Tlustý

Head of pricing

Dr.Max pharmacies

Miroslav is responsible for setting up and execution of pricing strategy in a chain of 400+ pharmacies in Czech Republic. Before joining Dr.Max in 2015 he spend 10 years in a different positions in area of pricing and revenue management. For 3 years he worked in revenue management of Czech Airlines. In this position he participated in implementation of optimization software for demand forecasting. Another 7 years he spent in banking as a head of pricing in Česká spořitelna, member of Erste group – the biggest bank in Czech Republic. Miroslav holds Master‘s degree in statistics at University of Economics in Prague. He participated in many pricing conferences and seminars.

Daniel Brath

Senior Pricing Manager, Global Patient Access

Novo Nordisk A/S

Daniel is a passionate Market Access manager with global experience across most market access disciplines. The last two years, he has been part of the team leading Value-based contracting in Novo Nordisk across the full portfolio.

The last two years has provided him and Novo Nordisk with a lot of learnings around designing and implementing contracts for chronic care, assessing the risks and developing the business cases. He is excited to share his learnings and hear from others and what they have learned

Pavel Slanina

Head of Pricing and Market Intelligence

ZENTIVA

Pavel Slanina is a Pricing Manager with 8 years of experience working in multiple B2B as well as B2C consumer healthcare, medical devices and pharmaceutical companies with strong focus on the EMEA region. His area of expertise is strategic pricing with emphasis on building strong functional relationships with marketing and sales teams in order to promote the value of pricing, drive value creation and build long-lasting and productive relationships.

Jonathan Hodgson

Senior Principal

Promidian and EVERSANA Company

Senior Principal, Promidian and EVERSANA Company

Bio: Jonathan has almost 20 years of experience helping biopharmaceutical companies make better strategic decisions in the areas of commercialization, research and development, portfolio planning, launch pricing and reimbursement, forecasting, asset valuation, and more across a broad range of therapeutic areas.

Jonathan’s experience spans both commercial and market-access questions and the development and application of both quantitative and qualitative insights. As such, he brings particularly deep expertise in leveraging innovative methodologies and large data sets to support analysis and strategic decision making.

He is an emerging leader in applying novel pricing methodologies to reimbursement for rare disease therapies. Jonathan has lectured on valuation approaches and techniques at the Massachusetts Biotechnology Council, and he co-authored “Biopharma: Beyond the First Product,” an in-depth look at critical success factors for growth of emerging biotechs, published in In Vivo.

Jonathan earned an MBA from Harvard Business School and a BA in economics from Dartmouth College.

 

Judith Imhof

Head of Pricing & Bids

Olympus Medical Systems Division (EMEA HQ)

Judith Imhof is Head of Pricing & Bids at Olympus Medical Systems (EMEA HQ). With a long term career path in MedTech and Health Care of 20+ years and a Business Administration background, she worked as Health Care Economist and Consultant. Integrated in Commercial Excellence at Olympus and having experience also in SFE initiatives, she builds up and leads the Pricing Excellence program and manages a central and regional team of Pricing Managers. With her broad experience level, Judith is passionate about driving change in complex organizational environments to create sustainable business results.

Markus Pöttker

Post Market Surveillance MDR Lead

Smith+Nephew

Markus is a member of the EU MDR Global Project team leading the Post Market Surveillance work stream at Smith+Nephew. In this role, he is responsible that the requirements of the EU MDR are correctly interpreted, specified and implemented across the business functions globally. Prior to this, he spent seven years in Quality & Regulatory roles, at last he was the Director of Complaint Management and Head of Regulatory Compliance, Complaint Intake and Closure at Smith+Nephew with global responsibility for Complaint Handling, Medical Device Reporting and interaction with Regulatory Agencies. Markus is a member of MedTech Europe PMS & Vigilance Working Group since 2012 and a member of the corresponding standard committee to ISO TC 210 at the Swiss Association for Standardization. Markus holds a masters degree in law (Diplom-Jurist) from WWU Münster, Germany. He is fluent in German and English.

Richard Rahul

Senior Manager

Monitor Deloitte Belgium

Richard Rahul is a Senior Manager in Monitor Deloitte. His core focus is on Life Sciences (Big pharma/medium pharma) and healthcare industries, besides health technology/digital health based firms. Richard’s expertise is in go-to market model optimization, innovative pricing models, value based selling, patient/customer experience design and operations, pricing and market access. He brings a global perspective having led and successfully executed engagements in the US, cross-EU and in China/India.

Sarah Pitluck

Head,Global Pricing and Reimbursement

SPARK THERAPEUTICS

Ms. Pitluck is the Head of Global Pricing & Reimbursement (P&R) at Spark Therapeutics. In her current role, Ms. Pitluck priced the first US Food and Drug Administration-approved gene therapy for a genetic disease, LUXTURNA® (voretigene neparvovec-rzyl). She is now working to ensure market access for all US patients in need of LUXTURNA including completing the first Centers for Medicare & Medicaid Services (CMS) demonstration project to provide alternate payment options and value-based arrangements for single-administration therapies like LUXTURNA.

Prior to joining Spark, she was the Executive Director for Global P&R at Alexion Pharmaceuticals, leading all global P&R efforts, including dossier preparation and negotiations for Alexion globally. She was formerly the Director of Genentech’s Coverage & Reimbursement Policy and responsible for all US public payer policy and reimbursement issues for Genentech’s products. She also worked at healthcare consulting companies including Avalere Health and Covance Health Economics and Outcomes Services Inc., focusing on policy and reimbursement analyses for a variety of pharmaceutical, biotechnology, and medical device products related to care settings and disease areas. Ms. Pitluck received her Masters of Science at the London School of Economics and Political Science.

Sara Carvalho

Title Senior Consultant, Global Pricing and Contracting

HighPoint Solutions, an IQVIA Company

Sara is a Senior Consultant with 4+ years of experience in Pricing and Tendering as well as in Commercial Excellence, based out of Geneva, Switzerland. She is responsible for leading projects within the Global Pricing and Tender Management practice from proposal development to project execution, management and oversight. Sara holds a Ph.D. in Evolutionary Genetics from the Instituto Gulbenkian de Ciencia/Universidade Nova de Lisboa, Portugal.

While at HighPoint Solutions, an IQVIA Company, Sara has worked with emerging, mid-tier and large pharma on various Tendering and Contracting programs as well as projects on bid price analysis and optimization, tender markets archetyping, tender landscape characterization for biologics and small molecules, assessment and implementation of tender management capabilities.

Cornelia Roibu

Consultant

Parexel Access Consulting

Cornelia Roibu is a consultant at Parexel, working in global pricing and market access, with substantial experience in helping manufacturers develop and optimize their assets’ value strategy, positioning, and payer negotiation strategy. Cornelia has strong expertise in immuno-oncology, orphan diseases, haematology and mental health, and is particularly interested in the challenges faced by the new potentially curative gene and cell-therapies.
Cornelia holds a Bachelor and Master of Biochemistry from the University of Oxford and is an author on several ISPOR posters, including one on the Romanian HTA system

Michael Tang

Senior Principal, P&MA

Parexel

Michael has over 10 years experience at Parexel working across pricing and market access and health economics and outcomes research. Michael has expertise in early evidence generation, planning and implementation to support product value with a particular focus on linking regulatory and market access and the pricing and reimbursement of novel, curative therapies

Giuseppe Monita

Director, Contracts, Tendering & Customer Services EMEA

Biocompatibles UK ltd, a Boston Scientific Company

Giuseppe graduated in International law to Pisa University faculty of International Political Science and obtained an MBA and an European master in marketing management and communications. He has almost 20 Years of experience in international sales operations and marketing management, MD&D, European Tender Management (more than 3000 Tenders successfully managed in EMEA). He is an expert in strategic and operational bid shaping in high competitive business environment. He has solid experience in public procurement in Europe, Middle East and Canada and has developed an extensive knowledge of the tender management at international level with specific knowledge of national legislations in the different European Countries. During these years he has faced all issues that companies encounter during tendering processes.

Filippo Gabbia

EMEA Strategic Tender Lead Medical Devices & Vice Chair of MedTech Public Procurement WG

Johnson & Johnson

21 years in the Health Care Industry with an extensive experience in Marketing and Sales at National and EMEA level. I hold a Master Certificate on Global Public Procurement Law and Policy from Nottingham University (UK) a Master of Philosophy of Management Research from LUISS University of Rome and a Business Management Degree from Venice University (IT).
Experienced sales and marketing manager I strongly believe that in order to succeed in the EU public driven Market we must define sharp and compliant tender value propositions that will allow us to navigate the complex public procurement ecosystem.

Maarten Moreels

Director

Monitor Deloitte Belgium

Maarten is a Director at Monitor Deloitte, leading the Commercial Excellence & Analytics team. Maarten is working primarily on projects at Life Sciences accounts, from strategic market review to tactical improvements in sales & marketing. His operational experience in sales & marketing from the industry enables him to identify the critical value levers and issues of clients.

 

Hans Demeyere

Senior Manager

Monitor Deloitte Belgium

Hans Demeyere is Senior Manager at Monitor Deloitte Belgium, focusing on Commercial Excellence topics. In the last 7 years, Hans performed projects mainly in LSHC related to GtN optimization programs within pharma & animal health, as well as supporting pricing transformation journeys incl. pricing analytics & tender management. In addition, Hans spent more than 2 years in Switzerland and 4 months in Brazil for business purposes.

Luca Porro

Sr. Manager Pricing, Global Cardiovascular and Europe Neuromodulation

LIVANOVA

Luca spent his entire 13 years’ career in Medical Devices, covering different roles in Marketing, Project Management, Business Development (M&A) and more recently Pricing. His main expertise is in the Cardiovascular and Neuromodulation spaces. He is based in Milan, Italy, and he worked on assignments in the USA, China and across Europe. Luca holds a MSc in Biomedical Engineering from Polytechnic University of Turin and an MBA from ESCP Europe. Since January 2019, he is leading Pricing at LivaNova for Cardiovascular globally and for all businesses in Europe.

TESTIMONIALS

Fresenius-Kabi SwissBioSim

Sue Caleo-Naeyaert, Global Head Pricing, Market Access and Policy Biosimilars at Fresenius-Kabi SwissBioSim

“This is a great conference which covers most pricing topics with a decent amount of detail. Anyone can benefit from this conference no matter how experienced”

Ian Tidswell

Ian Tidswell, Founder and Lead Consultant at een Consulting GmbH

The EPP Life Sciences Pricing Forum is a unique event for learning about the latest pricing challenges and techniques to address them, due to the deep experiences and skills of the participants and speakers

BTG

Giuseppe Monita , Senior Manager, Customer Services Contracts & Tendering EMEA at BTG

“Exciting & energetic meeting where it is possible to learn, share & discuss best practices and new ideas on hot topics regarding pricing & tendering” 

Cogentia Healthcare Consulting

David Alderson, Director at Cogentia Healthcare Consulting

“A good event for catching up, great networking and opportunity to share current thinking and best practice” 

Tefen Management Consulting

Chiara Garavaglia, Partner, Global Leader of Tefen Life Sciences Centre of Excellence & Innovation at Tefen Management Consulting

“In my experience, EEP is the only existing opportunity to discuss at 360 degrees about Pricing, involving both pharmaceutical and med tech stakeholders”

Sue Caleo-Naeyaert

Sue Caleo-Naeyaert , Global Head Pricing, Market Access and Policy Biosimilars at Fresenius-Kabi SwissBioSim

“This is a great conference which covers most pricing topics with a decent amount of detail.   Anyone can benefit from this conference no matter how experienced”

 

Henderson Azevedo

Henderson Azevedo, Global Pricing Oncology at Bayer

“A highly recommended forum for pricing professionals”

Alan Crowther

Alan Crowther, President, Global Markets at Alliance Life Sciences Consulting Group

“The 7th EPP Life Sciences Pricing Forum was the 3rd in a row that Alliance Life Sciences attended.  This year’s conference was the best yet in content. Participants come prepared to learn, share and together they helped shape the trends in our industry. The forum on the shores of Lake Geneva at the foot of the Alps is also the best locale you can imagine for a thought-provoking, content-rich conference. What a great atmosphere!”

Chiara Garavaglia

Chiara Garavaglia, Partner, Global Leader at Tefen Management Consulting

“In my experience, EEP is the only existing opportunity to discuss at 360 degrees about Pricing, involving both pharmaceutical and med tech stakeholders”

BD

, at

Baxter Healthcare

, at

Fresenius

, at

GSK

, at

Novo Nordisk

, at

Pfizer

, at

Philips Healthcare

, at

Cardinal Health

, at

Eisai

, at

Alcon

, at

Bristol-Myers Squibb

, at

Bracco Imaging

, at

Creative Ceutical

, at

Ferring

, at

Galderma

, at

GE healthcare

, at

Janssen

, at

Leica microsystems

, at

LFB

, at

Liva Nova

, at

Menarini

, at

NHS

, at

Novartis

, at

RIZIV

, at

Sanofi Aventis

, at

Shire

, at

Smith&Nephew

, at

Terumo

, at

TEVA

, at

UCB

, at

Tillots

, at

Meet pricing decision makers from:

VENUE / ACCOMMODATION

This year the 9th EPP Life Sciences Pricing Forum will take place in the Munich Airport Marriott Hotel.  The Munich Ariport Marriott Hotel is a beautiful venue located in a small relaxing town next to Munich.  The hotel is just a few minutes away from the airport and can be easily reached by a shuttle bus.

Address: Alois Steinecker Strasse 20, Freising 85354 Germany

We can offer you EPP preferred rates for your stay:  Book your rooms here.

 

CONTENT

Outcome-based pricing initiatives in the healthcare industry

A distorted reimbursement model has driven healthcare costs ever higher, and elevated healthcare spend to the top budget item for many governments across the globe. But several major industry players have begun to experiment with outcome-based pricing models as an innovative approach to align reimbursements more closely with positive outcomes, while simultaneously bringing greater stability and predictability to pricing in the life science industry.
This paper evaluates the current state of reimbursement models, the adjustments that need to be considered, and methods for reform while offering practical alternatives for both outcome-based pricing and payment methods for all stakeholders in the value chain.

The Evolving Landscape of biosimilars and its impact on the public procurement and tendering environment

Highpoint, an IQVIA company, has conducted various analysis to assess the impact of tenders for biosimilars and observed recent market trends as well as manufacturer behaviors to capture the subtle changes. Our findings translate into a comprehensive view on how companies could improve their bidding and tender strategy to succeed in this space. lastly, we provide our outlook on this topic emphasizing the importance for all stakeholders to find the right balance between cost containment for payers and sustainability for manufacturers to ensure that ultimately, patients and physicians will have multiple treatment options available.

Download your content here !

We hope you enjoy the content.

Get Brochure Get Brochure

EPP PARTNERSHIPS

For more info please contact Britt.dejager@pricingplatform.eu

MEDIA PARTNERS

REGISTRATION

. EPP Members benefit from our preferred membership rates – contact Britt Dejager
. Not yet a member ? Discover all EPP member benefits here 
• Once a registration is completed, tickets are transferable but never refundable. This applies to payments after invoice as well.

 

FULL CONFERENCE PASS

1995
Access to workshops
Access to 2 forum days
Access to evening event
PDF presentations after event
 
 

BUY 2 GET 1 FREE

3990
SAVE €1995 WITH THIS PASS
 
Access to workshops
Access to 2 forum days
Access to evening event
PDF presentations after event

BUY 3 GET 2 FREE

5989
SAVE € 3390 WITH THIS PASS
 
Access to workshops
Access to 2 forum days
Access to evening event
PDF presentations after event

FORUM PASS ONLY

1695
 
Access to 2 forum days
Access to evening event Oct 15th
PDF presentations after event
 
 

BUY 2 GET 1 FREE

3390
SAVE €1695 WITH THIS PASS
 
 
Access to 2 forum days
Access to evening event Oct 15th
PDF presentations after event

BUY 3 GET 2 FREE

5085
SAVE € 3390 WITH THIS PASS
 
 
Access to 2 forum days
Access to evening event Oct 15th
PDF presentations after event

PRE FORUM WORKSHOP ONLY

695
Access to pre-forum workshop only

Group discounts are available of > 3 people
Inquire

EXPERT FORUM PASS

2995
15-16 OCT
Access to the 2 forum days
Access to evening event
PDF presentations after event

GROUP RATES

on demand
Group discounts of > 2 people